Abano forecasts FY loss of $1.3M-$1.9M on sale of Aotea stake, Orthotics

Abano forecasts FY loss of $1.3M-$1.9M on sale of Aotea stake, Orthotics
By Jonathan Underhill April 24 (BusinessDesk) - Abano Healthcare expects to report a small full-year loss after the specialist medical investment firm agreed to sell its stake in Aotea Pathology and following the sale of its orthotics unit in January, which resulted in impairments on both businesses. The net loss is expected to be $1.3 million to $1.9 million in the year ending May 31, the Auckland-based company said in a statement. Excluding impairments and loss on sale, annual profit is forecast at $7.2 million to $7.8 million, up from...